Rx To Otc Switches Market

Rx-to-OTC Switches market: Global Industry Analysis 2013 - 2017 and Opportunity Assessment; 2018 - 2028

  • Ongoing
  • June 2020
  • REP-GB-9135
Rx To Otc Switches Market

  • US$5,000
  • US$7,500
  • US$10,000

This Rx To Otc Switches market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Rx To Otc Switches market.

Rx-to-OTC Switches: Market Insights

Rx-to-OTC switches are the process of converting Rx (prescription) medication to OTC (over-the-counter) non-prescription medications. Many new medicines have been introduced as Rx (prescription) medicines. Today, the Rx-to-OTC switches are trending among the manufacturers in the Rx-to-OTC switches market. The trend from Rx-to-OTC switches is expected to boost Rx-to-OTC switches market growth over the forecast period. The Rx-to-OTC switches is a highly regulated, data-driven, and scientifically rigorous process that allows consumers to have OTC access for a growing range of medicines. The Rx-to-OTC switches medicines allow a large number of patients to conveniently purchase and gain access to use a wide range of OTC medications without any prescriptions from healthcare professionals or physicians. The U.S. market for OTC medications is strong, affordable, providing consumers with accessible, and trusted healthcare options available 24/7 in a wide range of retail outlets such as pharmacies, drug stores, supermarkets, and convenience stores. The availability of OTC drugs without a prescription is expected to boost the growth of Rx-to-OTC switches, worldwide.

Rx-to-OTC Switches: Market Dynamics

The growing demand and sales for OTC medications around the world is the key factor to increase the Rx-to-OTC switches. Over the past few years, the Rx-to-OTC switches have increased tremendously. According to the list by the Food, Drugs, and Administration, in 2017, drug name Xyzal Allergy 24HR which is used to treat allergic rhinitis and perennial allergic rhinitis has switched from Rx-to-OTC. In 2016, drug name Flonase Sensimist Allergy Relief which used to treat allergic rhinitis and differin gel which is used to treat anti-acne has switched from Rx-to-OTC. Advantageously switching a medication from Rx to OTC opens up new opportunities and give potential market positioning. This trend has reduces the cost related to physicians visits. However, self-diagnosis not always correct which can lead to false medication and lead to complications and risk to individual health. This factor is expected to hamper the growth of Rx-to-OTC switches.

Market Growth Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

COVID -19 : Impact Analysis

Request the coronavirus impact analysis across industries and markets

Request Covid -19 Impact

Rx-to-OTC Switches market: Overview

The Rx-to-OTC switches medications authorize a large pool of self-diagnosed patients to gain tremendous public health benefits. This switch also provides affordable and more convenient options for a large patient pool and indirectly driving the growth of Rx-to-OTC switches market. However, due to the Rx-to-OTC switches drug abuse and overuse also has increased, globally. Most of the patients are unaware of the side-effects from OTC drugs and overdose the drug to attain relief. This increasing drug abuse and overdose may restrain the growth of Rx-to-OTC switches market.

Rx-to-OTC Switches market: Region-wise Outlook

North America is expected to show the highest revenue growth and to hold the largest market shares in the global Rx-to-OTC Switches market due to advanced healthcare infrastructure and healthcare spending. Additionally, increasing the adoption rate and demand will boost the Rx-to-OTC Switches market in this region, followed by Europe. The Rx-to-OTC Switches market in the Asia-Pacific region is expected to register the moderate growth due to low acceptance and high negligence rate for mental disorders and depression. Whereas, Latin America and the Middle East & Africa are expected to show stagnant Rx-to-OTC Switches market growth due to weak healthcare management for mentally disorder, depression and anxiety related disorders and low awareness.

Rx-to-OTC Switches market: Key Players

Some of the key players present in global Rx-to-OTC Switches market are AMS Group LLC., Kline & Company, Dolcera, Biotech Research Group Corporation, Diapharm, Nicholas Hall & Company, Consumer Healthcare Products Association, NDA Group AB, NCI Consulting LLC., Bates White, and others.

The report covers exhaustive analysis on:

  • Rx-to-OTC Switches Market Segments
  • Rx-to-OTC Switches Market Dynamics
  • Rx-to-OTC Switches Market Size
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Value Chain

The regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • The Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key Rx To Otc Switches Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

Rx-to-OTC Switches market: Segmentation

The global Rx-to-OTC switches market is segmented by drug categories, service providers and regions:

Rx-to-OTC Switches Segmentation by Drug Categories

  • Allergy and Cold
  • Nonsteroidal Anti-inflammatories
  • Fungal Infections
  • Overactive Bladder
  • Oral Contraceptives
  • Osteoporosis and Hormone Replacement Therapies
  • Antilipidemic Agents
  • Gastrointestinal Drugs
  • Viral Infections Hair Loss Treatments
  • Migraine Therapy
  • Sleep Agents
  • Smoking Cessation
  • Sexual Dysfunction
  • Others

Rx-to-OTC Switches Segmentation by Service Providers

  • Strategy and Marketing Consultants
  • Clinical Research Labs
  • CROs/CMOs
  • Drug After-Market Manufacturers/Suppliers
  • Legal/Regulatory Advisors
  • Statistical Service Providers
  • Marketing Organizations

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
Frequently Asked Questions

Why choose FMI?
  • With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
  • Market Reports researched and peer reviewed by industry experts from across the globe
  • We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
  • In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
  • Primary research includes mandatory field interviews with stakeholders involved
  • Customizing reports according to client specification is also our forte
  • The current and future market size, covering each aspect and nuanced trends across key national and geographic markets
  • An overview of the market report, providing an imperative visual of the varied market subdivisions and overall forecast statistics in terms of value and volume
  • Extensive database and key dynamics elevating the market with varied verticals associated
  • Underlying Rx To Otc Switches Market forces that are compelling consumers or businesses to purchase the product
  • How novel technologies and consumer-centric innovations will create new value-adding opportunities for companies active in the Rx To Otc Switches Market
  • What will be environment and regulatory impacts on the market over the next decade
  • Investment Feasibility Matrix - It shows returns on investment, level of competition, success rate of investment, and potential risks associated with the market. The analysis shows that the competition is high in the established market, while the returns for short-term investment are also taken into consideration
  • Relative Maturity Mapping – The relative maturity is measured according to three growth phases (growth, maturity, decline)
  • Relative PLC (Product Life Cycle) – Analysis of the emergence of prominent players and competitive test prices which are driving factors behind every market. (expected market behavior, observed market behavior, expected market performance, observed market performance)
Get in touch
Harish Tiwari

Harish Tiwari

Global Head - Business Development

* indicates mandatory fields
Our Clients

Request Sample Request customization Request Methodology